MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzora Cream in Greater China - Marketscreener.com
MDVI Stock | ILA 32.50 0.50 1.56% |
About 55% of Medivie Therapeutic's investor base is interested to short. The analysis of current outlook of investing in Medivie Therapeutic suggests that many traders are impartial regarding Medivie Therapeutic's prospects. The current market sentiment, together with Medivie Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Medivie Therapeutic stock news signals to limit their universe of possible portfolio assets.
Medivie |
MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzora Cream in Greater China Marketscreener.com
Read at news.google.com
Medivie Therapeutic Fundamental Analysis
We analyze Medivie Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medivie Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medivie Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Medivie Therapeutic is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Medivie Therapeutic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medivie Therapeutic stock to make a market-neutral strategy. Peer analysis of Medivie Therapeutic could also be used in its relative valuation, which is a method of valuing Medivie Therapeutic by comparing valuation metrics with similar companies.
Peers
Medivie Therapeutic Related Equities
GLPL | Golan Plastic | 6.73 | ||||
ABRA | Abra Information | 1.48 | ||||
INRM | Inrom Construction | 1.48 | ||||
AMAN | Amanet Management | 1.26 | ||||
FEAT | Feat Fund | 0.00 | ||||
BCOM | B Communications | 0.06 | ||||
ICL | ICL Israel | 1.53 |
Complementary Tools for Medivie Stock analysis
When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |